Contact Center Industry News

TMCNet:  Integrity Applications Signs Additional Distribution Agreement for GlucoTrack® Model DF-F Glucose Monitoring Device

[January 14, 2014]

Integrity Applications Signs Additional Distribution Agreement for GlucoTrack® Model DF-F Glucose Monitoring Device

ASHKELON, Israel --(Business Wire)--

Integrity Applications, Inc. (OTCQB: IGAP), developer of the GlucoTrack® model DF-F non-invasive blood glucose measurement device, has entered into a distribution agreement appointing Kocak Medical & Laboratory Technology Ltd. as the exclusive distributor of the GlucoTrack device in Turkey effective February 14, 2014. According to the International Diabetes Federation, more than 7 million diabetes patients live in Turkey, representing approximately 15 percent of the nation's adult population.

Sercan Kocak, CEO of Kocak Medical & Laboratory Technology Ltd., said, "We believe diabetes patients in Turkey, as elsewhere in the world, are in need of new blood glucose monitoring options. The GlucoTrack® model DF-F non-invasive blood glucose measurement device offers this patient population an innovative alternative that we expect to have widespread appeal. We are pleased to be working with Integrity Applications to facilitate this significant advance in diabetes care. We will also maintain a dedicated website providing detailed information about the GlucoTrack and where diabetes patients will be able to purchase the device in Turkey."

Sales of GlucoTrack in Turkey are expected to begin by the end of the second quarter of 2014, and will be made available to diabetes patients through the channels to be announced on Based on the minimum purchase requirements contained in the distribution agreement, Kocak Medical & Laboratory Technology Ltd. is expected to purchase a minimum of $4,000,000 of GlucoTrack model DF-F devices from Integrity Applications in the first contract year. Kocak Medical & Laboratory Technology, established in 1992, is one of the leading distributors of medical, laboratory and genetic products in Tukey.

Avner Gal, President and CEO of Integrity Applications, said, "This milestone marks our second distribution agreement for GlucoTrack® and we look forward to providing patients with diabetes a new, non-invasive option for monitoring blood glucose. I am confident that the diabetes community in Turkey, as well as other nations, will embrace this tool as a fresh alternative to existing (invasive) blood glucose monitoring options."

GlucoTrack features a small sensor that clips to the earlobe and measures the wearer's blood glucose level by taking measurements using three technologies. The measurements are analyzed using a proprietary algorithm and displayed on a small handheld device, the size of a mobile phone. The derived blood glucose measurement is also announced verbally, making it suitable for the elderly and vision-impaired diabetes patients. The company has obtained a CE Mark for its GlucoTrack Model DF-F in Europe and intends to seek Food and Drug Administration approval for GlucoTrack in the United States.

To watch a video detailing the benefits of GlucoTrack, please visit the following link:

About Integrity Applications, Inc.

Integrity Applications, Inc. is a medical device company focused on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes. Integrity Applications has developed the GlucoTrack model DF-F non-invasive glucose monitoring device, which is designed to help people with diabetes obtain blood glucose level measurements without the pain, inconvenience, incremental cost and difficulty or discomfort of conventional (invasive) spot finger stick devices. Integrity Applications works primarily through its wholly-owned Israeli subsidiary, A.D. Integrity Applications, Ltd. For more information please visit

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "expect," and "will," are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect Integrity Applications' actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect Integrity Applications' results include, but are not limited to, the ability of Integrity Applications to successfully commercialize the GlucoTrack DF-F; the ability of the GlucoTrack DF-F to achieve acceptable pricing, adequate third party reimbursement or market acceptance; the ability of Integrity Applications to manage its growth and the expansion of its operations to include commercialization activities; risks relating to the use of third party manufacturers; risks relating to the development of Integrity Applications' sales, marketing and distribution capability, either on its own or through collaborations with marketing partners; and the additional risk factors described in Integrity Applications' filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2012.

[ Back To Cloud Contact Center's Homepage ]


Featured Resources

Featured Report
Millennial Research on Customer Service Expectations

Millennial Research on Customer Service Expectations

The "why" behind this research is simple: our clients recognize that different generations bring different expectations, varied communication preferences and new customer service patterns to the customer experience...
Featured Report
Optimizing the Customer Experience through Cloud Contact Centers

Optimizing the Customer Experience through Cloud Contact Centers

Adoption of cloud contact centers is on the rise. Findings from Aberdeen's January 2014 'Public Cloud vs. On-Premise: How to More Effectively Deploy a Cloud Center' study shows that 31% of contact centers are deployed in the cloud, and our related blog post highlights that companies anticipate their adoption of cloud technology to rise further throughout 2014...
Featured Report
Aberdeen report

Aberdeen Report: Cloud for Mid-Sized Contact Centers – What You Must Know

Cloud Technology is opening new doors for many businesses. However, it does so only when it's combined with the use of best practices and key technology enablers. This document highlights the adoption of cloud technology by mid-size contact centers and illustrates the reasons driving their investments...
Featured Whitepaper
Aberdeen report

Seven Critical Capabilities to Demand From Your Cloud Contact Center Provider

To deliver a world-class customer experience, your contact center must be flexible and reliable, while providing all the tools agents and supervisors need to manage their workflows. Here are seven critical capabilities to look for when deploying a contact center in the cloud...
Featured Webinar

Contact Center Economics and the Cloud

Together, Bob and Drew will help you understand the economic value of upgrading technology, important business and financial considerations, and how to compare total cost of ownership of a premises vs. cloud or hosted solution. Watch the webinar on-demand now...
Featured Datasheet
Zipwire Cloud Contact Center

Zipwire Cloud Contact Center

The appeal of moving services to the cloud is obvious. Cloud services offer reliability and robust feature sets without the need to implement or maintain complex contact center infrastructure. The Zipwire™ cloud-based contact center allows businesses to leverage the flexibility and cost savings of cloud architecture while offering a seamless, first-class customer experience...